| Serial Number | 87090968 |
| Word Mark | SYNEURX |
| Filing Date | Friday, July 1, 2016 |
| Status | 704 - PARTIAL SECTION 8 ACCEPTED |
| Status Date | Wednesday, October 2, 2024 |
| Registration Number | 5419035 |
| Registration Date | Tuesday, March 6, 2018 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 23, 2017 |
| Goods and Services | Pharmaceutical products and substances for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; medicines for neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; pharmaceutical preparations for neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; sodium salts for medical purposes |
| Goods and Services | [ Pharmaceutical preparations and drug development services for developing drugs for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Biological research; Clinical lab test of medical reagents for conducting clinical trials for others in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Scientific research and analysis in the field of medical reagents; Providing research and development of technology in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Technical research in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Technical project studies in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Scientific laboratory services ] |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | B - Sec. 8 - Class(es) in a Multiple Class registration |
| Class Status Date | Wednesday, October 2, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, March 14, 2016 |
| First Use In Commerce Date | Monday, March 14, 2016 |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, July 6, 2016 |
| Primary Code | 005 |
| First Use Anywhere Date | Saturday, May 31, 2014 |
| First Use In Commerce Date | Saturday, May 31, 2014 |
| Party Name | SyneuRx International Corp. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Taipei City 110 TW |
| Party Name | SyneuRx International Corp. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Taipei City 110 TW |
| Party Name | SyneuRx International Corp. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Taipei City 110 TW |
| Event Date | Event Description |
| Thursday, October 13, 2016 | NON-FINAL ACTION WRITTEN |
| Tuesday, July 5, 2016 | NEW APPLICATION ENTERED |
| Wednesday, July 6, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, October 12, 2016 | ASSIGNED TO EXAMINER |
| Thursday, October 13, 2016 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, October 13, 2016 | NON-FINAL ACTION E-MAILED |
| Friday, March 31, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, March 31, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, April 1, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, April 14, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 3, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 23, 2017 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 23, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 18, 2017 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, January 18, 2018 | TEAS STATEMENT OF USE RECEIVED |
| Thursday, January 18, 2018 | USE AMENDMENT FILED |
| Tuesday, January 30, 2018 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, January 30, 2018 | STATEMENT OF USE PROCESSING COMPLETE |
| Tuesday, January 30, 2018 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Wednesday, January 31, 2018 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, March 6, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, January 25, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, January 25, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, January 25, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, March 6, 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Wednesday, February 21, 2024 | TEAS SECTION 8 RECEIVED |
| Wednesday, September 25, 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Wednesday, October 2, 2024 | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED |
| Wednesday, October 2, 2024 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED |